Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

48.63 +0.36 (+0.75%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

40 41 Next >

Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review ↗

April 29, 2022

The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings.

Via Investor's Business Daily

Dupixent, Consumer Healthcare Lifts Sanofi's Q1 Earnings, Backs FY22 Guidance ↗

April 28, 2022

Via Benzinga

Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again ↗

April 28, 2022

Dupixent sales rocketed higher in the quarter, driven by continued uptake in eczema treatment.

Via Investor's Business Daily

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates ↗

April 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Did Truist Lower IGM Biosciences' Price Target? ↗

March 30, 2022

Via Benzinga

Earnings Scheduled For April 28, 2022 ↗

April 28, 2022

Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion.

Via Benzinga

Why Is IGM Biosciences (IGMS) Stock Up Today? ↗

March 29, 2022

Here are the various catalysts investors in IGM Biosciences and IGMS stock are watching today as shares more than double.

Via InvestorPlace

Microsoft Gives Glimpse Of Xbox Cloud Gaming Numbers ↗

April 27, 2022

Microsoft Corporation (NASDAQ: MSFT) CEO Satya Nadella said Tuesday that more than 10 million people have streamed games on its Xbox Cloud Gaming platform. What Happened: Nadella...

Via Benzinga

This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels ↗

April 26, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a...

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran ↗

April 25, 2022

Terran Biosciences is slowly but surely finding its place in the psychedelics industry.

Via Benzinga

Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ ↗

April 22, 2022

Via Benzinga

4 Undervalued Biotech Stocks to Add to Your Buy List ↗

April 20, 2022

These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.

Via InvestorPlace

How To Attend Sanofi Q1 2022 Earnings Conference Call ↗

April 19, 2022

Sanofi (NASDAQ:SNY) will host a conference call at 08:30 AM ET on April 28, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ ↗

April 18, 2022

In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a...

Via Benzinga

Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine ↗

April 14, 2022

Via Benzinga

Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027

April 13, 2022

Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent...

Via FinancialNewsMedia

BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines ↗

April 11, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Friday Stocks Update ↗

April 08, 2022

Royal Dutch Shell rose again on its earnings but is still at a p/e ratio of under 11x earnings.

Via Talk Markets

Stocks That Hit 52-Week Highs On Thursday ↗

April 07, 2022

On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...

Via Benzinga

What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates? ↗

April 07, 2022

Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.

Via Benzinga

The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More ↗

April 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation ↗

April 07, 2022

The

Via Benzinga

Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ ↗

April 05, 2022

Via Benzinga

Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May ↗

April 01, 2022

Sanofi SA (NASDAQ: SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business.

Via Benzinga

House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month ↗

April 01, 2022

The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.

Via Benzinga

EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine ↗

March 30, 2022

Via Benzinga

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict ↗

March 30, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide ↗

March 29, 2022

U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sanofi - American Depositary Shares (NQ:SNY)

All News about Sanofi - American Depositary Shares

Starting at $3.75/week.

Subscribe Today